Bird I N, Spragg J H, Ager A, Matthews N
Yamanouchi Research Institute, Littlemore Hospital, Oxford, U.K.
Immunology. 1993 Dec;80(4):553-60.
CD31 is a 130,000 MW cell-surface glycoprotein expressed on endothelial cells, polymorphonuclear leucocytes, monocytes and about 50% of peripheral blood lymphocytes, and it has been proposed that it plays a role in transendothelial migration. If it is involved in endothelial transmigration of lymphocytes then the proportion of CD31+ cells should be increased in the lymphocyte population which has crossed an endothelial monolayer. This was tested using two endothelial types, namely human umbilical vein endothelial cells (HUVEC) and rat high endothelial venule (RHEV) cells. As a control, lymphocyte CD45RA and CD45RO expression was also determined since there is a correlation between lymphocytes bearing these isoforms and different migratory patterns. Double labelling techniques showed a close correlation between CD31 and CD45RA expression. With HUVEC monolayers, the transmigrated lymphocyte population was depleted of CD31+ cells. This depletion was even more marked if the HUVEC monolayers had been stimulated with interleukin-1 beta (IL-1 beta). The migrated lymphocytes were enriched for CD31-CD45RO+ cells but depleted of CD31+CD45RA+ cells. In addition, lymphocyte populations depleted of CD31+ cells by immunopanning were also able to migrate across HUVEC monolayers. Taken together these data suggest that lymphocyte CD31 expression is not necessary for transmigration across HUVEC monolayers and, if anything, is negatively correlated with transmigration. With the second endothelial cell type, RHEV cells, there was no consistent change in the proportion of CD31+ lymphocyte in the transmigrated population, suggesting neither a positive nor a negative correlation between CD31+ expression and lymphocyte transmigration across RHEV cells. However, with both endothelial cell types, the migrated lymphocyte populations were enriched for the marker CD45RO. In conclusion, lymphocyte surface expression of CD31 is not necessary for transmigration across the endothelial cell types used in this study, but with both cell types an enrichment of CD45RO+ lymphocytes is seen in the migrated population.
CD31是一种分子量为130,000的细胞表面糖蛋白,在内皮细胞、多形核白细胞、单核细胞和约50%的外周血淋巴细胞上表达,有人提出它在跨内皮迁移中起作用。如果它参与淋巴细胞的内皮迁移,那么在穿过内皮单层的淋巴细胞群体中,CD31+细胞的比例应该会增加。使用两种内皮细胞类型进行了测试,即人脐静脉内皮细胞(HUVEC)和大鼠高内皮微静脉(RHEV)细胞。作为对照,还测定了淋巴细胞CD45RA和CD45RO的表达,因为携带这些异构体的淋巴细胞与不同的迁移模式之间存在相关性。双标记技术显示CD31和CD45RA表达之间密切相关。对于HUVEC单层,迁移后的淋巴细胞群体中CD31+细胞减少。如果用白细胞介素-1β(IL-1β)刺激HUVEC单层,这种减少会更加明显。迁移的淋巴细胞富含CD31-CD45RO+细胞,但CD31+CD45RA+细胞减少。此外,通过免疫淘选去除CD31+细胞的淋巴细胞群体也能够穿过HUVEC单层迁移。综合这些数据表明,淋巴细胞CD31表达对于穿过HUVEC单层迁移不是必需的,而且如果有任何关联的话,与迁移呈负相关。对于第二种内皮细胞类型RHEV细胞,迁移群体中CD31+淋巴细胞的比例没有一致的变化,这表明CD31+表达与淋巴细胞穿过RHEV细胞的迁移之间既没有正相关也没有负相关。然而,对于两种内皮细胞类型,迁移的淋巴细胞群体都富含标记物CD45RO。总之,CD31在淋巴细胞表面的表达对于穿过本研究中使用的内皮细胞类型迁移不是必需的,但对于两种细胞类型,在迁移群体中都可以看到CD45RO+淋巴细胞增多。